John D. McLaren - Concepedia

Author

John D. McLaren

University of Michigan

Also Known As

J McLaren, J.D. McLaren, John D McLaren, John D. McLaren, John D. Mclaren, John McLaren, John Mclaren, McLaren, John D.

Publications

980

Citations

H-Index

Concepts

All Affiliations

University of Michigan University of Aberdeen Children's Hospital of Los Angeles Kansas State University

About

John D. McLaren is an author at University of Michigan specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	772
2	Health Sciences	5	5	317
3	Natural Sciences	3	3	63
4	Engineering	1	1	47
5	Social Sciences	1	1	14

John D. McLaren

Publications

920

Citations

H-Index

Page 1

	Year	Citations
Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague–Dawley rat Wei-Jing Wu, Su-Hua Sha, John D. McLaren, Hearing Research Molecular PharmacologyBiochemistryMedicineAdult CbaToxicology	2001	229
Glutathione-dependent antioxidant systems in the mammalian inner ear: effects of aging, ototoxic drugs and noise J. Lautermann, Sherry A. Crann, John D. McLaren, Hearing Research Mammalian Inner EarHealth SciencesGlutathione-dependent Antioxidant SystemsMedicinePhysiology	1997	134
Glutathione protection against gentamicin ototoxicity depends on nutritional status J. Lautermann, John D. McLaren, Jochen Schacht Hearing Research Health SciencesDietary ExposureMedicineNutraceutical IngredientGlutathione Protection	1995	123
The effect of post type and length on the fracture resistance of endodontically treated teeth John D. McLaren, Charles I. McLaren, Peter Yaman, Journal of Prosthetic Dentistry Dental BiomechanicsFracture ResistancePost TypeRoot Canal TreatmentOrthopaedic Surgery	2009	65
Formation of a toxic metabolite from gentamicin by a hepatic cytosolic fraction Sherry A. Crann, May Y. Huang, John D. McLaren, Biochemical Pharmacology Hepatic Cytosolic FractionBiochemistryToxic MetaboliteMedicineLiver Physiology	1992	56
Diet is a risk factor in cisplatin ototoxicity J. Lautermann, Benbo Song, John D. McLaren, Hearing Research NutritionOncologyDietary ExposureCisplatin OtotoxicityMedicine	1995	51
Characterization of Implantable Microfabricated Fluid Delivery Devices R. Rathnasingham, Daryl R. Kipke, Sanford C. Bledsoe, IEEE Transactions on Biomedical Engineering EngineeringFormal CharacterizationMicrofabricationBioelectronicsPhysiology	2004	47
In vivo release of neuroactive amino acids from the inferior colliculus of the guinea pig using brain microdialysis Jeffrey D. Goldsmith, Sharon G. Kujawa, John D. McLaren, Hearing Research NeurophysiologyNeuroanatomyMedicinePhysiologyNeurotransmitter	1995	32
Pyridine Nucleotide Metabolism in Escherichia coli John D. McLaren, Domingo T. C. Ngo, Baldomero M. Olivera Journal of Biological Chemistry Chemical BiologyBiosynthesisBiotransformationPyridine Nucleotide MetabolismBiochemistry	1973	30
Induction of poly(ADP-ribosyl)ation in the kidney after in vivo application of renal carcinogens John D. McLaren, Teni Boulikas, Spiridon Vamvakas Toxicology Renal CarcinogensUrologyMedicineRenal PathologyRenal Pathophysiology	1994	27

Page 1